0001610717-24-000160.txt : 20240313
0001610717-24-000160.hdr.sgml : 20240313
20240313163201
ACCESSION NUMBER: 0001610717-24-000160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Margaret A
CENTRAL INDEX KEY: 0001294192
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 24746411
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-03-11
0001628171
Revolution Medicines, Inc.
RVMD
0001294192
Horn Margaret A
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
Chief Operating Officer
true
Common Stock
2024-03-11
4
M
0
15735
4.09
A
158202
D
Common Stock
2024-03-11
4
S
0
15735
34.0201
D
142467
D
Common Stock
2024-03-12
4
M
0
7936
4.09
A
150403
D
Common Stock
2024-03-12
4
S
0
7936
34.0657
D
142467
D
Stock Option (Right to Buy)
4.09
2024-03-11
4
M
0
15735
0
D
2023-03-13
2029-03-12
Common Stock
15735
52567
D
Stock Option (Right to Buy)
4.09
2024-03-12
4
M
0
7936
0
D
2023-03-13
2029-03-12
Common Stock
7936
44631
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023.
Includes 100,013 restricted stock units.
This transaction was executed in multiple trades in prices ranging from $34.00 to $34.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $34.00 to $34.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Jack Anders, as Attorney-in-fact for Margaret Horn
2024-03-13